{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
PROCEPT BioRobotics Corp.
Is PROCEPT BioRobotics Corp. technically bullish or bearish?
As of October 31, 2025, PROCEPT BioRobotics Corp. has shifted to a bearish trend, supported by negative technical indicators and significant underperformance against the S&P 500, with year-to-date and one-year returns of -57.14% and -62.61%, respectively.
Is PROCEPT BioRobotics Corp. technically bullish or bearish?
As of October 31, 2025, PROCEPT BioRobotics Corp. is in a bearish trend with weak strength, indicated by bearish MACD readings, Bollinger Bands, and moving averages, despite a bullish weekly RSI, and has underperformed the S&P 500 with a year-to-date return of -57.74%.
Is PROCEPT BioRobotics Corp. technically bullish or bearish?
As of October 31, 2025, PROCEPT BioRobotics Corp. is in a bearish trend with weak strength indicators, underperforming the S&P 500 significantly, showing a year-to-date return of -57.74% compared to the index's 16.30%.
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $32.11
PROCEPT BioRobotics Corp. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. Despite reporting positive results for seven consecutive quarters, the company remains unprofitable, with a negative P/E ratio and a high price-to-book ratio, indicating premium valuation.
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $32.46
PROCEPT BioRobotics Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,165 million, has reported consecutive positive results but faces challenges, including substantial operating cash flow and net profit losses.
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $33.83
PROCEPT BioRobotics Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,165 million, operates at a loss and faces challenges such as negative return on equity and high debt-to-equity ratio.
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $34.05
PROCEPT BioRobotics Corp. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. Despite reporting positive results for seven consecutive quarters, the company faces financial challenges, including negative return on equity and EBITDA, raising concerns about its market position.
PROCEPT BioRobotics Corp. Hits 52-Week Low at $35.31 Amid Decline
PROCEPT BioRobotics Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,165 million, operates at a loss and has reported negative returns, despite achieving positive results for the last seven quarters.
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $35.53
PROCEPT BioRobotics Corp. has reached a new 52-week low, reflecting a significant decline in stock performance over the past year. Despite reporting positive results for seven consecutive quarters, the company remains unprofitable, with a negative price-to-earnings ratio and a high price-to-book ratio, indicating premium valuation.
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $36.77
PROCEPT BioRobotics Corp. has reached a new 52-week low of USD 36.77, reflecting a 45.57% decline over the past year. The company, with a market cap of USD 2,165 million, reports negative returns and cash flow challenges despite recent positive quarterly results. Its stock is considered risky due to high valuations and underperformance.
Is PROCEPT BioRobotics Corp. technically bullish or bearish?
As of August 6, 2025, PROCEPT BioRobotics Corp. is in a bearish trend, indicated by negative MACD readings, moving averages, and KST, while significantly underperforming the S&P 500 with year-to-date and one-year returns of -52.77% and -54.16%, respectively.
Is PROCEPT BioRobotics Corp. overvalued or undervalued?
As of November 4, 2021, PROCEPT BioRobotics Corp. is considered risky and overvalued, with a Price to Book Value of 8.94 and negative financial metrics, while underperforming the S&P 500 with a year-to-date return of -52.77%.
Is PROCEPT BioRobotics Corp. overvalued or undervalued?
As of November 4, 2021, PROCEPT BioRobotics Corp. is considered overvalued and risky due to its negative P/E ratio and poor financial metrics, with a year-to-date decline of 27.05%, contrasting sharply with its peers and the S&P 500's modest gain.
Is PROCEPT BioRobotics Corp. technically bullish or bearish?
As of June 11, 2025, the technical trend is mildly bearish, indicated by daily moving averages and reinforced by the stock trading below its previous close and near its 52-week low, despite some mildly bullish signals from weekly indicators.
What does PROCEPT BioRobotics Corp. do?
PROCEPT BioRobotics Corp. is a small-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $69 million and a net loss of $25 million as of March 2025. Key metrics include a market cap of $3.27 billion, a P/E ratio of NA, and a dividend yield of 0%.
How big is PROCEPT BioRobotics Corp.?
As of Jun 18, PROCEPT BioRobotics Corp. has a market capitalization of 3,265.50 million, with net sales of 249.12 million and a net profit of -90.20 million over the latest four quarters. Shareholder's funds were 402.22 million, and total assets were valued at 534.02 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
